BIO UV (France) Performance
| ALTUV Stock | 1.66 0.07 4.05% |
The firm shows a Beta (market volatility) of -0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BIO UV are expected to decrease at a much lower rate. During the bear market, BIO UV is likely to outperform the market. At this point, BIO UV Group has a negative expected return of -0.29%. Please make sure to confirm BIO UV's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if BIO UV Group performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BIO UV Group has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 12.3 M | |
| Total Cashflows From Investing Activities | -20.7 M |
BIO |
BIO UV Relative Risk vs. Return Landscape
If you would invest 204.00 in BIO UV Group on September 4, 2024 and sell it today you would lose (38.00) from holding BIO UV Group or give up 18.63% of portfolio value over 90 days. BIO UV Group is generating negative expected returns and assumes 2.0946% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than BIO, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BIO UV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIO UV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIO UV Group, and traders can use it to determine the average amount a BIO UV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1408
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALTUV |
Estimated Market Risk
| 2.09 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BIO UV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIO UV by adding BIO UV to a well-diversified portfolio.
BIO UV Fundamentals Growth
BIO Stock prices reflect investors' perceptions of the future prospects and financial health of BIO UV, and BIO UV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIO Stock performance.
| Return On Equity | 0.0769 | |||
| Return On Asset | 0.0347 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 75.36 M | |||
| Shares Outstanding | 10.21 M | |||
| Price To Book | 1.52 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 33.46 M | |||
| EBITDA | 3.97 M | |||
| Cash And Equivalents | 361.07 K | |||
| Total Debt | 26.32 M | |||
| Book Value Per Share | 3.19 X | |||
| Cash Flow From Operations | 3.3 M | |||
| Earnings Per Share | 0.24 X | |||
| Total Asset | 81.12 M | |||
About BIO UV Performance
Assessing BIO UV's fundamental ratios provides investors with valuable insights into BIO UV's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the BIO UV is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about BIO UV Group performance evaluation
Checking the ongoing alerts about BIO UV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIO UV Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BIO UV Group generated a negative expected return over the last 90 days | |
| BIO UV Group may become a speculative penny stock |
- Analyzing BIO UV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIO UV's stock is overvalued or undervalued compared to its peers.
- Examining BIO UV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIO UV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIO UV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIO UV's stock. These opinions can provide insight into BIO UV's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for BIO Stock Analysis
When running BIO UV's price analysis, check to measure BIO UV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO UV is operating at the current time. Most of BIO UV's value examination focuses on studying past and present price action to predict the probability of BIO UV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO UV's price. Additionally, you may evaluate how the addition of BIO UV to your portfolios can decrease your overall portfolio volatility.